器官芯片的上次“突飞猛进”大约是在两年前。2022年，FDA动作频繁：器官芯片在内的数据被首次用于FDA新药申请；在FDA和药企、Biotech公司推动下，从参议院到众议院，美国国会终于将对动物试验的非强制性写进法案。伴随着FDA的几个大动作，市场情绪一步步高涨。2022年前后也是国内器官芯片开始崭露头角的时候，数家器官芯片公司获得融资。

Platform adopted by 10 of the top 25 biopharmaceutical companies, by U.S. governmental agencies, and by academic research centers worldwide Organs-on-Chips enable drug developers and researchers to ...

Organ-on-a-chip maker Emulate has launched an upgraded offering for researchers studying inflammatory bowel disease with its tissue model that helps illustrate how immune cells are activated and ...

BOSTON--(BUSINESS WIRE)--Emulate, Inc., today announced that Jim Corbett has been appointed as Chief Executive Officer and Martin Madaus, Ph.D., has been appointed Executive Chairman of the company’s ...

Emulate has raised $82 million in a series E round to help further develop and commercialize its organ-on-a-chip technology. The Boston, MA company has raised a total of $225 million since it was ...

Bellevue, WA, Oct. 28, 2025 (GLOBE NEWSWIRE) -- EMulate Therapeutics, a pioneering digital therapeutics company, announces the launch of its community funding round ...

Emulate, Inc., the leading provider of next-generation in vitro Organ-Chip models, today announced the release of its new Chip-R1™ Rigid Chip, designed to minimize drug absorption and enhance ...

Small cellular models of human tissue can help researchers better understand how the body reacts under rare conditions. Now, Emulate’s organ-on-a-chip will help explore one of the rarest of all: how ...

Medical device maker Emulate Therapeutics (EMTX) has set terms for a proposed IPO that would raise around $13M. Emulate said in a filing that it is looking to offer 2.5M shares priced between $4 and ...

Emulate and Laboratory Corp. of America’s Covance unit have formed a partnership to assess “organs on chips” technology for preclinical drug evaluation. Emulate will bring to the partnership its ...

Emulate is the leading provider of next generation in vitro biological models. Researchers use their organ-on-a-chip technology to understand and predict drug response with greater precision and ...